Clinical Trial Update: Evaluating the Effects of Tasimelteon vs. Placebo in Delayed Sleep-Wake Phase Disorder (DSWPD) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating tasimelteon versus placebo for delayed sleep-wake phase disorder is active/not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Delayed Sleep-wake Phase Disorder

Drugs mentioned

• Tasimelteon (tasimelteon)

Snippet

Sponsor: Vanda Pharmaceuticals | Conditions: Sleep Wake Disorders, Sleep Disorders, Circadian Rhythm | Phase 3 | Status: ACTIVE_NOT_RECRUITING